Present study population | Graz | Innsbruck | Vienna | Mannheim | |
---|---|---|---|---|---|
Number of BALs/patients | 149/133 | 70/61 | 51/49 | 18/13 | 10/10 |
Sex | |||||
Male | 87 (65.4%) | 45 (51.7%) | 28 (32.2%) | 6 (6.9%) | 8 (9.2%) |
Female | 46 (34.6%) | 16 (34.8%) | 21 (45.7%) | 7 (15.2%) | 2 (4.3%) |
Median age (range) | 60 (19 to 85) | 66 (19 to 83) | 58 (26 to 85) | 59.5 (41 to 74) | 55.5 (40 to 75) |
Type of ICU admission (BALs) | |||||
Medical | 121/149 (81.2%) | 60/70 (85.7%) | 35/51 (68.6%) | 16/18 (88.9%) | 10/10 (100%) |
Neurologic | 6/149 (4%) | 5/70 (2.9%) | 1/51 (2%) | – | – |
Elective surgery | 2/149 (1.3%) | – | 1/51 (2%) | 1/18 (5.6%) | – |
Emergency surgery | 8/149 (5.4%) | 4/70 (5.7%) | 4/51 (7.8%) | – | – |
Trauma | 12/149 (8.1%) | 1/70 (1.4%) | 10/51 (19.6%) | 1/18 (5.6%) | – |
Primary underlying disease (BALs) | |||||
Pulmonary disease | 44/149 (29.5%) | 21/70 (30%) | 14/51 (27.5%) | 6/18 (33.3%) | 3/10 (30%) |
Heart disease | 25/149 (16.8%) | 17/70 (24.3%) | 4/51 (7.8%) | 4/18 (22.2%) | – |
Hematologic malignancies | 19/149 (12.8%) | 8/70 (11.4%) | 3/51 (5.9%) | 2/18 (11.1%) | 6/10 (60%) |
Trauma | 12/149 (8.1) | 1/70 (1.4%) | 10/51 (19.6%) | 1/18 (5.6%) | – |
Neurologic disease | 14/149 (9.4%) | 11/70 (15.7%) | 3/51 (5.9%) | – | – |
Gastrointestinal disease | 13/149 (8.7%) | 3/70 (4.3%) | 7/51 (13.7%) | 3/18 (16.7%) | – |
Metabolic disease | 4/149 (2.7%) | 1/70 (1.4%) | 3/51 (5.9%) | – | – |
Other malignancies | 5/149 (3.4%) | 3/70 (4.3%) | 2/51 (3.9%) | – | – |
Rheumatologic disease | 4/149 (2.7%) | 3/70 (4.3%) | – | – | 1/10 (10%) |
Others | 9/149 (6%) | 2/70 (2.9%) | 5/51 (9.8%) | 2/18 (11.1%) | – |
IPA classification | |||||
Proven IPA (BALs/patients) | 4/2 | – | – | 3/1 | 1/1 |
Probable IPA (BALs/patients) | 16/14 | 6/6 | 8/7 | 2/1 | – |
Possible IPA (BALs/patients) | 21/20 | 6/5 | 6/6 | – | 9/9 |
No IPA (BALs/patients) | 108/97 | 58/50 | 37/36 | 13/11 | – |